Explore the Agenda
8:30 am Thought Leadership Workshop in Partnership with Foundation Medicine
12:00 pm Thought Leadership Workshop in Partnership with Roche
From Concept to Commercialization: Navigating Multimodal Strategy & Early IVD Migration
Join Roche for an interactive workshop session featuring rapid technology demonstrations, live polling, table-based breakouts, candid networking and fireside chats.
- Part 1: The Oncology Story – From Discovery to Standard of Care: This segment focuses on digital pathology, computational pathology, and multiplexing. We will highlight the strategic value of moving the IVD development process earlier into the drug timeline and include an interactive session for attendees to map regulatory and operational hurdles.
- Part 2: Beyond Tissue – Non-Oncology & Multimodality: This section explores precision medicine in immunology and neurology, examining how multi-omic data is reshaping clinical trials and how to manage multimodal complexity across a drug’s lifecycle.
3:30 pm Thought Leadership Engager in Partnership with Natera
Rethinking Clinical Development with ctDNA-MRD: From Early Signals to Late-Phase Strategy
Natera is hosting an interactive working session on how ctDNA-MRD can reshape clinical development strategy and approaches, both as a biomarker to identify underserved patients that can potentially be cured with novel therapies and as a response assessment tool to accelerate both early-phase and late-phase clinical trial insights.
Attendees will break into three focused groups based on their role and interests.
6:15 pm Dinner Conversations in Partnership with Guardant Health
AI is Everywhere: Where is the Impact in Drug Discovery & Development?
Biopharma teams have access to more data than ever before—yet turning genomic, epigenomic, and clinical data into actionable insights remains a major challenge.
Join Guardant Health for a discussion on how next-generation AI tools are helping researchers navigate complex biological datasets, accelerate hypothesis generation, and uncover new opportunities for therapeutic development.
We'll share recent innovations from Guardant Health, demonstrate emerging AI-powered research capabilities, and highlight real-world examples of how biopharma organizations are using Guardant Health’s InfinityAI and multi-omic data to drive discovery programs forward.
Whether you're evaluating AI strategies or looking for practical applications that deliver scientific value today, this session will provide actionable insights and lessons learned from real-world deployments.
If you would like to join us for the engager and workshop sessions, please select one of the Conference + Engager/Workshop ticket options during registration.
*Please note, attendance at these workshop and engager sessions are subject to availability and approval by the session partners.